News

No. Title Writer Date Inquiry
22 A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders.
관리자 23.05.19 Inquiry : 1,708
관리자 23.05.19 1,708
21 Activity of a Novel Anti-Inflammatory Agent F-3,6′-dithiopomalidomide as a Treatment for Traumatic Brain Injury
관리자 23.01.17 Inquiry : 1,907
관리자 23.01.17 1,907
20 3,6′- and 1,6′-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt Inflammation
관리자 23.01.17 Inquiry : 1,683
관리자 23.01.17 1,683
19 Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis.
관리자 23.01.17 Inquiry : 1,796
관리자 23.01.17 1,796
18 Researches on immunomodulatory imides drug development under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, Int J Mol Sci. (July 31, 2021).
관리자 23.01.17 Inquiry : 1,839
관리자 23.01.17 1,839
17 The therapeutic efficacy results of a candidate immunomodulatory imide drug developed under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, ACS P
관리자 23.01.17 Inquiry : 1,746
관리자 23.01.17 1,746
16 Research on the immunomodulatory imide drugs development under the Cooperative Research and Development Agreement(CRADA) with the National Institutes of Health(NIH) have been published in the peer-reviewed publication, Frontiers in Neuroscience(March 2)
관리자 23.01.17 Inquiry : 1,636
관리자 23.01.17 1,636
15 The therapeutic efficacy results of a candidate immunomodulatory imide drug developed under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, eLife
관리자 23.01.17 Inquiry : 1,665
관리자 23.01.17 1,665
14 The 6th Target Protein Dissolution Summit
관리자 23.06.22 Inquiry : 1,845
관리자 23.06.22 1,845
13 Patent license agreement with KRICT
관리자 23.05.19 Inquiry : 1,768
관리자 23.05.19 1,768